Natrunix
2021-PT055
Phase 2 small_molecule completed
Quick answer
Natrunix for Rheumatoid Arthritis is a Phase 2 program (small_molecule) at XBiotech Germany GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- XBiotech Germany GmbH
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed